3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
13
Recruiting
8
Unknown
4
Not yet recruiting
3
Active not recruiting
3
Withdrawn
1
Terminated
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Neoplasms
40
Breast Neoplasms
38
Prostatic Neoplasms
24
Colorectal Neoplasms
23
Uterine Cervical Neoplasms
16
Carcinoma, Non-Small-Cell Lung
13
Anxiety Disorders
13
Stomach Neoplasms
9
Lymphoma, Follicular
9
Leukemia, Myeloid, Acute
9
Carcinoma, Hepatocellular
9
Brain Neoplasms
9
Lung Neoplasms
8
Head and Neck Neoplasms
8
Urinary Bladder Neoplasms
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Esophageal Neoplasms
7
Sarcoma
6
Ovarian Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Depression
6
Colonic Neoplasms
6
Uterine Cervical Dysplasia
5
Small Cell Lung Carcinoma
5
Pain
5
Glioma
5
Epilepsy
5
Dementia
5
Cholangiocarcinoma
5
Squamous Cell Carcinoma of Head and Neck
4
Interventions
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Interventional
×
Intermittent Fasting
×
Clear all
NCT06645093
2026-03-10
FasteStudien
University of Oslo
Phase NA
Enrolling by invitation
40 enrolled